(Q38571980)

4 September 2017

title

Marijuana Use in Epilepsy: The Myth and the Reality (English)

1 reference

4 September 2017

Kamil Detyniecki

1

1 reference

4 September 2017

Lawrence Hirsch

series ordinal

2

1 reference

4 September 2017

publication date

1 October 2015

1 reference

Current Neurology and Neuroscience Reports

4 September 2017

published in

1 reference

4 September 2017

volume

15

1 reference

4 September 2017

issue

10

1 reference

4 September 2017

page(s)

65

1 reference

https://scigraph.springernature.com/pub.10.1007/s11910-015-0586-5

4 September 2017

exact match

0 references

cites work

Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0586-5

Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0586-5

Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0586-5

Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0586-5

Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0586-5

Pure cannabidiol in the treatment of malignant migrating partial seizures in infancy: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0586-5

The case for medical marijuana in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0586-5

Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0586-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0586-5

Cannabinoid induced behavioral convulsions in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0586-5

Δ9-tetrahydrocannabinol: Subcortical spike bursts and motor manifestations in a fischer rat treated orally for 109 days

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0586-5

Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0586-5

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0586-5

Is lipid signaling through cannabinoid 2 receptors part of a protective system?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0586-5

The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0586-5

The case for assessing cannabidiol in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0586-5

Adverse health effects of marijuana use

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0586-5

Effect of long-term cannabis use on axonal fibre connectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0586-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0586-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0586-5

Comparison in the In Vitro Inhibitory Effects of Major Phytocannabinoids and Polycyclic Aromatic Hydrocarbons Contained in Marijuana Smoke on Cytochrome P450 2C9 Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0586-5

Cannabidiol, a major phytocannabinoid, as a potent atypical inhibitor for CYP2D6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0586-5

Cannabis and other illicit drug use in epilepsy patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0586-5

Marijuana use and epilepsy: prevalence in patients of a tertiary care epilepsy center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0586-5

Fewer specialists support using medical marijuana and CBD in treating epilepsy patients compared with other medical professionals and patients: result of Epilepsia's survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0586-5

Intractable epilepsy: A survey of patients and caregivers

21 January 2018

1 reference

12 December 2020

Effects of cannabidiol on behavioral seizures caused by convulsant drugs or current in mice

1 reference

12 December 2020

Cannabidiol--antiepileptic drug comparisons and interactions in experimentally induced seizures in rats

1 reference

12 December 2020

Anticonvulsant properties of Δ9-tetrahydrocannabinol and other cannabinoids

1 reference

12 December 2020

Grand mal convulsions subsequent to marijuana use. Case report

1 reference

12 December 2020

Cannabinoids for epilepsy

1 reference

12 December 2020

Potent inhibition of human cytochrome P450 3A isoforms by cannabidiol: role of phenolic hydroxyl groups in the resorcinol moiety

1 reference

12 December 2020

Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses.

1 reference

12 December 2020

Marihuana research findings: 1976: Summary

1 reference

12 December 2020

Current and former marijuana use: preliminary findings of a longitudinal study of effects on IQ in young adults

1 reference

12 December 2020

10.1007/S11910-015-0586-5

Identifiers

DOI

1 reference

Dimensions Publication ID

4 September 2017

1019290427

0 references

1 reference